1. Lenalidomide Induces Responses in Patients with MDS-DEL(5)Q Alone, or with One Additional Abnormality, Irrespective of Who Classification and Prognostic Categorization. (April 2017) Authors: Symeonidis, A.; Kouraklis-Symeonidis, A.; Galanopoulos, A.; Hatzimichael, E.; Zikos, P.; Vassilakopoulos, T.; Pappa, V.; Kotsianidis, I.; Dimou, M.; Palla, K.; Viniou, N.A.; Kartasis, Z.; Pontikoglou, C.; Barbarousi, D.; Pagoni, M.; Xanthopoulidis, G.; Kotsopoulou, M.; Michali, E.; Katodritou, E.... Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT). (12th June 2019) Authors: Vassilakopoulos, T.P.; Papageorgiou, S.G.; Michail, M.; Angelopoulou, M.K.; Kourti, G.; Kalpadakis, C.; Kotsopoulou, M.; Leonidopoulou, T.; Konstantinidou, P.; Kotsianidis, I.; Boutsis, D.; Michali, E.; Sachanas, S.; Terpos, E.; Karianakis, G.; Poziopoulos, C.; Vadikolia, C.; Pigaditou, A.; Vraki... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗